balsalazide disodium
Active substance: balsalazide disodium
CAPSULE · BALSALAZIDE DISODIUM 750 mg/1
United StatesActive
Marketing holder: Zydus Lifesciences Limited
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
- Countries with the substance registered: 1
Composition
- BALSALAZIDE DISODIUM · 750 mg/1
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208c-296e-7f8d-8284-beffe5e0b34e,01a1208c-bcda-7ac0-9cc4-dc46136edf01,01a12090-08ec-7d30-b2b0-ada1330ce08c,01a12093-940f-7918-8d07-19c6fa7a04cf,01a12094-6095-7c8b-b8c9-3acdac05f678;count=9 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 70771-1841
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- ORAL
Sources
- product · openFDA NDC · 70771-1841 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 70771-1841 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 70771-1841 · Verified 2026-10-09 · open in source